Adaptimmune Therapeutics Plc (ADAPY)
0.037
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Adaptimmune Therapeutics Net Income (Quarterly) : -30.72M for June 30, 2025
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2025 | -30.72M |
| March 31, 2025 | -47.77M |
| December 31, 2024 | -73.53M |
| September 30, 2024 | -17.80M |
| June 30, 2024 | 69.60M |
| March 31, 2024 | -48.48M |
| December 31, 2023 | -48.33M |
| September 30, 2023 | -45.34M |
| June 30, 2023 | -21.46M |
| March 31, 2023 | 1.045M |
| December 31, 2022 | -29.47M |
| September 30, 2022 | -41.07M |
| June 30, 2022 | -44.13M |
| March 31, 2022 | -49.98M |
| December 31, 2021 | -38.91M |
| September 30, 2021 | -42.21M |
| June 30, 2021 | -38.99M |
| March 31, 2021 | -37.89M |
| December 31, 2020 | -36.92M |
| Date | Value |
|---|---|
| September 30, 2020 | -36.07M |
| June 30, 2020 | -29.95M |
| March 31, 2020 | -28.18M |
| December 31, 2019 | -29.76M |
| September 30, 2019 | -39.06M |
| June 30, 2019 | -40.88M |
| March 31, 2019 | -27.70M |
| December 31, 2018 | -35.87M |
| September 30, 2018 | 5.25M |
| June 30, 2018 | -43.31M |
| March 31, 2018 | -21.22M |
| December 31, 2017 | -27.64M |
| September 30, 2017 | -0.8833M |
| June 30, 2017 | -20.44M |
| March 31, 2017 | -21.99M |
| December 31, 2016 | -15.34M |
| September 30, 2016 | -18.49M |
| June 30, 2016 | -21.86M |
| March 31, 2016 | -15.42M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Oxford Biomedica Plc | -- |
| Kiniksa Pharmaceuticals International Plc | 25.43M |
| Autolus Therapeutics Plc | -39.18M |
| Bicycle Therapeutics Plc | -50.42M |
| Scancell Holdings Plc | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 13.85M |
| Total Expenses (Quarterly) | 44.56M |
| EPS Diluted (Quarterly) | -0.1163 |